ATNM - Actinium Pharmaceuticals, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 2.10
52-Week Change 3-74.01%
S&P500 52-Week Change 37.98%
52 Week High 30.7810
52 Week Low 30.1900
50-Day Moving Average 30.2231
200-Day Moving Average 30.2822

Share Statistics

Avg Vol (3 month) 3634.72k
Avg Vol (10 day) 3426.84k
Shares Outstanding 5162.43M
Float 153.73M
% Held by Insiders 11.30%
% Held by Institutions 112.47%
Shares Short (Sep 30, 2019) 43.51M
Short Ratio (Sep 30, 2019) 48.62
Short % of Float (Sep 30, 2019) 43.00%
Short % of Shares Outstanding (Sep 30, 2019) 42.16%
Shares Short (prior month Aug 30, 2019) 43.89M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-65.72%
Return on Equity (ttm)-140.32%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -23.11M
Net Income Avi to Common (ttm)-23.17M
Diluted EPS (ttm)-0.1880
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.52M
Total Cash Per Share (mrq)0.12
Total Debt (mrq)1.42M
Total Debt/Equity (mrq)9.03
Current Ratio (mrq)3.85
Book Value Per Share (mrq)0.10

Cash Flow Statement

Operating Cash Flow (ttm)-21.75M
Levered Free Cash Flow (ttm)-13.44M